Market Exclusive

DYNATRONICS CORPORATION (NASDAQ:DYNT) Files An 8-K Results of Operations and Financial Condition

DYNATRONICS CORPORATION (NASDAQ:DYNT) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition.

On November 14, 2017, Dynatronics Corporation issued a press release to report the results of its operations for the first fiscal quarter ended September 30, 2017. The release also announced that the Company would hold a conference call with investors by telephone and provided access information, date and time for the conference call.

The information in this Current Report is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document to the Securities Act of 1933, as amended. The furnishing of the information in this Current Report is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information this Current Report contains is material investor information that is not otherwise publicly available.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

99.1 Press Release of Dynatronics Corporation dated November 14, 2017.

DYNATRONICS CORP ExhibitEX-99.1 2 exh99_1.htm PRESS RELEASE OF DYNATRONICS CORPORATION DATED NOVEMBER 14,…To view the full exhibit click here
About DYNATRONICS CORPORATION (NASDAQ:DYNT)
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

Exit mobile version